Savara Inc Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Savara Inc (SVRA) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $96.00 million as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-13
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $96.00M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $25.30M; Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed $25.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $9.50M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $3.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2025-12-31 | $96.00M 10-K · filed 2026-03-13 | |
| 2024-12-31 | $25.30M 10-K · filed 2026-03-13 | $25.00M 10-K · filed 2025-03-27 |
| 2023-12-31 | $9.50M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $3.50M 10-K · filed 2024-03-07 | |
| 2021-12-31 | $3.50M 10-K · filed 2023-03-30 | $3.60M 10-K · filed 2022-03-30 |
| 2020-12-31 | $2.90M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |